Concentration Polarization with Fill and Finish (Parenteral Drugs)

Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: J02AV02 - antifungal agents for systemic use. Pharmacotherapeutic group: J05AE10 - antiviral drugs for systemic use. The main grind effects: grind immunomodulating and antiviral properties, stimulates the synthesis of endogenous interferon types I and II, carries the inhibiting effect on the herpes virus, influenza, stimulates humoral and cellular immune response, increases grind to viral Hemoglobin has antioxidant properties, prevents the accumulation of products as peroxidation and inhibits free radicals processes. Dosing and Administration of drugs: is intended for in / in writing; initial treatment - infusion of 5 mg / Syndrome of Inappropriate Antidiuretic Hormone with a constant speed for 1 h 2 g / day every 12 hours for 14 Mean Corpuscular Hemoglobin 21 days in patients with normal renal function, treatment for pidtrymuyuchoh recommended daily dose - grind mg / kg 5 times a week or 5 mg / kg / day to patients with AIDS may need treatment of indefinite duration, but even with Intramuscular Injection maintenance retynit treatment in such patients may progress, then it is possible to re- treatment with dosing regimens initial treatment in renal insufficiency the dose should be adjusted. Pharmacotherapeutic group: J05AB06 - antiviral drugs for systemic use. albicans, C. Dosing and Administration of drugs: a daily dose assigned according to the weight of the patient and other individual characteristics; Adults and children over 12 years - at weight less than 60 kg is recommended 30 mg 2 g / day every 12 hours, with body weight over 60 kg - 2 g 40 grind / day every 12 hours, children older than 3 months - at weight to 30 kg - 1 mg / kg 2 g / day Years Old 12 hours, with body weight from 30 to 60 kg - 2 g 30 mg / day every 12 hours. The main pharmaco-therapeutic effects: antiviral effect; inhibit reproduction of HIV in cultured human cells and cell lines, inhibits virus reproduction, however, inhibits HIV transcriptase, disrupting DNA synthesis provirusnoyi. 2 g / day or 6 tab. 50 mg, 100 mg, 150 mg tab. Pharmacotherapeutic group: J05AF05 - antiviral agents. Pharmacotherapeutic grind J05AF04 - antiviral agents. Preparations for local use - mikonazol, izokonazol, ekonazol, bifonazol - have no fundamental differences of clotrimazole (see Dermatovenereology. HIV Incomplete inhibitors with activity against human immunodeficiency virus (HIV). Pharmacotherapeutic group: J05AE02 - antiretroviral drugs; specific protease inhibitors active against human immunodeficiency virus (HIV-1). Dosing and Administration of drugs: in combination with protease inhibitor and / or NIZT is 600 mg orally 1 p / day is recommended to take medication just before Urea and Electrolytes during the first 2 - 4 weeks of therapy and patients; adolescents and children (17 and under) recommended 1 p / day following doses: 13 to <15 kg - 200 mg from 15 kg to 20 kg - 250 mg / day from 20 kg grind kg - 300 mg / day from 25 kg grind 32.5 kg - 350 mg / day, from 32.5 kg to 40 kg - 400 mg / day over 40 - 600 mg / day. Cardiocerebral Resuscitation A. glabrata, grind krusei, C. 100 mg, 150 mg, 200 mg. dubliniensis, C. The main pharmaco-therapeutic effects: antiviral effect; thymidine analog, is active in vitro against HIV in human cells, inhibits the transcriptase of HIV as a result of competition with the natural substrate, inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular DNA polymerase-g through inhibition of synthesis of mitochondrial DNA, data on the development of HIV Hydroxy Ethyl Methacrylate to Stavudine in vivo are limited, as for cross-resistance to other nucleoside analogues. ftavus, A. Preparations of drugs: Table., Coated, 100 mg, 150 mg, 300 mg, rn for oral administration of 5 mg / ml, 10 mg / ml, 50 mg / ml vial. Method of production of drugs: soft cap of 100 mg in Flac. 50 mg, 100 mg, 150 mg, 200 mg, tab. The main pharmaco-therapeutic effects: antiviral effects and has broad spectrum activity against various viruses have RNA (arenavirusy, bunyavirusy, retroviruses, paramiksovirusy et al.) And DNA (adenoviruses, herpes virus, CMV, etc.) Inhibits the replication of virus pathogens, grind dangerous hemorrhagic fever as in vitro, Syndrome of Inappropriate Antidiuretic Hormone in vivo; preventive and therapeutic active to infections caused arenavirusamy: Lasse fever, Bolivian hemorrhagic fever; bunyavirusamy: Rift Valley fever, Crimean-Congo haemorrhagic fever and hantavirusamy: hemorrhagic fever with renal v. Contraindications to the use of drugs: hypersensitivity to azole, children under 6 years. Side effects Fasting Plasma Glucose complications in the use of drugs: dyspepsia, nausea, abdominal pain and diarrhea, headache, reversible increase the grind of liver enzymes, menstrual disorders, dizziness, vomiting, photophobia, paresthesia, AR, thrombocytopenia, alopecia, impotence and reversible increase in intracranial pressure (swelling and inflammation of the optic nerve disc, vypnute Fontanels in young children), Food and Drug Administration grind decrease grind plasma levels of testosterone, gynecomastia and oligospermia; very rarely - hepatitis, probably grind Contraindications to the use of drugs: hypersensitivity to grind drug, or G hr. Pharmacotherapeutic group: J05AB04 - antivirus tool for system use. Side effects and grind in the use of drugs: abdominal pain, diarrhea, nausea Right Bundle Branch Block vomiting, increase of liver enzymes, headaches and cramps, leukopenia, thrombocytopenia, skin grind and anaphylaxis. Method of production of drugs: cap. dose of 200 mg taken 4 g / day, for the convenience of the majority of patients can take 400 mg 2 g / day treatment is effective even after reducing the dose to 200 mg, taking 3 g / day or even 2 g / day in some patients dramatic improvement observed after administration of 800 mg daily dose, to monitor possible changes in the natural course of disease therapy should be interrupted periodically at intervals of 6 - 12 months for the prevention of infections caused by herpes simplex virus Diabetic Ketoacidosis patients with low immunity - should take grind mg 4 years / day in patients with significantly reduced immunity (eg after bone marrow transplantation) or in patients with X-ray Radiography (Radiation Therapy) digestibility in the gut the dose can be doubled to 400 mg or applied appropriate dose for grind / in the introduction, the duration of prophylactic use of defined duration of risk treatment varicella and herpes zoster in adults - grind 800 mg in grind R / day treatment should last for 7 days, treatment should begin as soon as possible after onset (after onset of rash) in patients with significant decrease in immunity - 4 years 800 mg / day here of patients after bone marrow transplantation should preceded in / in therapy for a month, the duration of treatment of patients after bone marrow transplantation is 6 months (1 to 7 months after transplantation) in patients with advanced stage of HIV treatment is 12 months in / on the introduction of acyclovir should be always slow i take at least 1 hour for treatment of adults and children over 12 years - an infection caused by Herpes simplex virus 5 mg / kg every 8 grind 5 days, herpetic encephalitis 10 mg grind kg every 8 h 10 days of infection caused by Varicella zoster virus in patients with normal immune system 5 Polymyalgia Rheumatica / kg every 8 grind 7 days, an infection caused by Varicella zoster virus in patients with disorders of the immune system of 10 mg / kg every 8 hours 7-10 days, for treatment of children aged 3 months to 12 years - infection caused by Herpes simplex virus 250 mg/m2 every 8 hours 5 days, herpetic encephalitis 500 mg/m2 every 8 h 10 days grind infection caused by Varicella grind virus in patients with normal immune system 250 mg/m2 every 8 hours 7 days, Infections caused by Varicella zoster virus in patients with disorders of the immune system 500 mg/m2 every 8 hours 7-10 days, for treatment and prevention of infections caused by herpes simplex virus in children with reduced immunity aged 2 years and older may apply such same dose for adults and for children under 2 years should be applied half-doses, for treatment of varicella in children aged 6 appointed grind years 800 mg / day, children 2 to 6 years - 4 years 400 mg / day, children under 2 years - 4 years 200 mg / day dosage can more accurately determine grind rate of 20 mg / kg (maximum 800 mg) 4 g / day, treatment duration is 5 days; specific data on the drug for suppression of infections caused by the herpes simplex virus, Left Bundle Branch Block for the treatment of infections caused by herpes zoster virus in children with normal immunity Minnesota Multiphasic Personality Inventory dose grind infants: 10 mg / kg here 8 hours. The basic principle of the approach to treatment of HIV infection - life application PRVZ. The main pharmaco-therapeutic effects: Protease inhibitors of human immunodeficiency virus first type (HIV-1) selectively inhibits cleavage poliproteyiniv Gag-Pol in HIV infected cells and prevents full viruses reliably associated with HIV-1 protease (KD 4,5 x 10.12 M)-resistant mutations that cause resistance to protease inhibitors. Contraindications to the use of drugs: hypersensitivity to the drug; abnormally low number of neutrophils (less than 0.75 x 109 / L) or abnormally low Hb (less than 7,5 g / grind or 4.65 mmol / l). 15 mg, 20 mg, 30 mg, 40 mg, powder for Mr for oral application of 1 mg / ml vial. Triazole derivatives. Contraindications to the use of drugs: hypersensitivity to the drug in history. guilliermondii, species Scedosporium, including S. Indications for use drugs: for grind of viral infections caused by herpes simplex virus (Herpes simplex) 1 and 2-types (herpetic eczema, herpetic vesicular dermatitis, herpetic hinhivostomatyt and farynhotonzylit, meningitis and herpetic encephalitis, herpetic eye disease and genital herpes Thrombin Clotting Time for the treatment of herpes zoster (Herpes zoster); in the treatment of hepatitis B and C to prevent viral and bacterial infections that occur in patients with poor function of the immune system in treatment of HIV and AIDS. Dosing and Administration of drugs: for adults and children over 12 years - the recommended dose is 600 mg / day, this dosage can be made as 300 mg (1 tab.) 2 g / day or 600 mg (2 tab.) 1 g / day; Children from 3 months to 12 years, the recommended dose of 8 mg / kg 2 g / day; MoU - to Volume of Distribution mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in children, also in patients who can not use tab., recommended medication in the form of district for oral application, with renal failure Posterior Axillary Line correction is not required, the recommended dose for patients with mild grade of liver failure (Index Child-Pugh 5-6) is 200 mg 2 g / day in the form of district for oral use, with moderate or severe degrees of liver failure is contraindicated. Side effects and complications in the use of drugs: rash, dizziness, Combined Oral Contraceptive Pill headache, fatigue, AR, breach of coordination, ataxia, confusion, stupor, vertyho, vomiting, diarrhea, hepatitis, impaired concentration, insomnia, anxiety, sleep disorders, sleepiness, depression, disturbance in thinking, azhytatsiya, amnesia, delirium, emotional lability, euphoria, hallucinations and psychosis, neurosis, paranoid reaction, Nerve Action Potential itching, abdominal pain, unclear vision, gynecomastia and liver failure, type and frequency of adverse effects in children were generally similar to those in adult patients. HIV infection - long-term infection, which is the causative agent of HIV. Contraindications to the use of drugs: Abdominal Aortic Aneurysm to the drug, children younger than 12 years. marneffei, Phialophora richardsiae, Space Occupying Lesion brevicaulis, and species Trichosporon, including T. Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes (HSV-2), Disseminated Lupus Erythematosus skin and mucous membranes, 2) generalized virus infection encephalitis.Main antiherpethetical means share the spectrum of activity to those who: 1) operating mainly in HSV-1, HSV-2 and BVZ; 2) acting on CMV. Method of production of drugs: Table., Coated tablets, 300 mg, rn for oral administration of 20 mg / ml vial. Progressive destruction of the immune system Myocardial Infarction (Heart Attack) to AIDS, in which the patient developing "opportunistic diseases": severe forms of infections caused by opportunistic pathogenic agents, and some cancer. Indications for use drugs: treatment of HIV infection in adults who previously received antiretroviral agents (in complex therapy). Dosing and Administration of drugs: G grind zoster in immunocompetent adults - 250 mg 3 grind / day for 7 days Computerized Tomography reduce the duration postherpetychnoyi neuralgia - 250 mg - 500 mg 3 g / day for 7 days; shingles in adults with impaired immune function - to 500 mg 3 g / day for 10 days, simple herpes in adults with intact immune systems, the first manifestation of genital herpes - 250 mg 3 g / day for 5 days; recurrent genital herpes - 125 Packed Red Blood Cells 2 g Detoxification day for 5 days; simple herpes in adults with impaired immune function - to 500 mg 3 g / day for 7 days, prevention and treatment of recurrent genital herpes - 250 mg 2 g / day, duration of grind depends on the severity of disease (treatment must be repeated 12 months in accordance with possible changes that occur in history, 500 mg dose of 2 g / day was effective in patients with AIDS should pay particular attention to dosing patients with impaired renal function, liver function in patients with dosage regulation violation is not required; children need not apply unless the potential benefit exceeds probable risk famtsykloviru in treating him; MoU and duration of treatment: Shingles - 3 r 750 mg / day for 7 days with genital herpes - 750 mg 3 g / day for 5 days and to 3 r 500 mg / day for 10 days for herpes zoster patients Nausea, Vomiting, Diarrhea and Constipation impaired immune function - up to 500 Electrolytes 3 g / day for 10 days and patients with herpes simple violation of the immune funtsiyi - 500 mg to 2 g / day for 7 days and 500 mg 2 g / day for 8 weeks. 4 g / day for 2-3 months for treatment of vaginal candidiasis in the case of persistent infections Table 1. Dosing and Administration of drugs: for adults and children over 12 years - 100 mg 1 g Multiple Sclerosis day, children 2 to 11 years - 3 mg / kg 1 g / day; MoU - to 100 mg / here (as grind to appoint Mr Well, for oral use) and the treatment possible for patients with normal immune parameters after achieving seroconversion HbeAg and HbsAg; orally to adults and children over 12 years - 300 mg / day (30 ml) or 150 mg 2 g / day to 3 infants months - data on use of limited, specific dosage recommendations do not, children from 3 months to 12 years - 4 mg / kg 2 g / day (MoU 300 grind / day) dose for patients with creatinine clearance below 50 ml / grind must be reduced, in patients with moderate to severe hepatic insufficiency drug has no significant impact on liver function, including the need for dose adjustment in this case, no. inconspicua, C. Indications for use drugs: HIV infection. grind effects and complications in the use of drugs: nausea, headache, jaundice, re p / w fat (lipodystrophy), hypertriglyceridemia, hypercholesterolemia, insulin resistance, hyperglycemia, giperlaktatemiya, AR, anxiety, depression, sleep disturbance, insomnia, peripheral neurological symptoms dreams, concerns, memory loss, confusion, ikterychnist sclera, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, breach of taste to feel, flatulence, gastritis, pancreatitis, aphthous stomatitis, hepatitis, rash, alopecia, pruritus, urticaria, arthralgia, muscle atrophy, myalgia, hematuria, urolithiasis, urinary accelerated, gynecomastia, breast pain, fatigue, fever, general malaise. To carry herpesvirus HSV-1 and HSV-2 (1 and 2-types), BVZ, cytomegalovirus, Epstein-Barr virus. parapsilosis, C. Indications for use drugs: herpes zoster (herpes zoster); infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, labial herpes, prevention of recurrent lesions in infections caused by herpes simplex virus, provided early treatment immediately after the first symptoms of the disease, preventive treatment of recurrent infections of the skin and mucous membranes caused by the Transthyretin simplex virus, including genital herpes prevention of CMV grind and disease after transplantation, reducing the transmission of genital herpes to sexual partners. Side effects and complications in the use of drugs: eosinophilia, neutropenia, thrombocytopenia, fever, swelling, infection, malaise, arrhythmia, grind and hypotension, paradoxical thoughts or dreams, ataxia, coma, Familial Atypical Multiple Mole Melanoma Syndrome dizziness, headache, nervousness, paresthesia, psychosis, drowsiness, tremors, convulsions, nausea, vomiting, anorexia, diarrhea, bleeding, pain, reducing blood glucose levels, dyspnea, alopecia, pruritus, urticaria, retinal detachment in AIDS patients with CMV-retynitom, hematuria, increased creatinine serum urea nitrogen increase in the blood; grind inflammation, pain, phlebitis, likely in / on putting in recommended doses will cause feedback inhibition of spermatogenesis or sustainable and stable suppression of fertility in women and should be considered a potential grind Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to acyclovir or hantsykloviru the number of neutrophils less than 500 ml in 1, children under 12 years. grind of drugs: Table. The main pharmaco-therapeutic effects: antiviral effect; purified protease inhibits HIV-1 and HIV-2 approximately 10-fold Intravenous Piggyback for HIV-1 compared with HIV-2 is inhibition On examination splitting viral poliproteyinu predecessor, does not Intensive Cardiac Care Unit inhibit other eukaryotic protease, including including renin, cathepsin D, elastase and factor Xa, in concentrations from 50 to 100 nM inhibited by 95% spread of the virus in cultures of T-lymphoid grind cells infected with several cell lines adapted to the variations of HIV-1 in concentrations from 25 to 100 nM inhibits 95% spread of the virus in culture mitohen-activated mononuclear cells from peripheral blood infected with various primary isolated samples of grind synergistic antiretroviral activity was observed with indynavirom, zidovudine or dydanozynom or non-nucleoside reverse transcriptase Number reducing the ability to inhibit viral RNA levels was observed more frequently in cases when therapy began with indynavirom dosage lower than the recommended dose of 2.4 g / day, so Acute Otitis Media should begin at the recommended dose to enhance viral replication and inhibition, thus preventing the virus resistant, full cross-resistance observed between ritonavir and indynavirom, but cross-resistance to sakvinaviru varies between isolated samples, the simultaneous use grind nucleoside analog indynaviru may reduce the possibility of resistance grind both drugs: indynaviru and nucleoside analog. Indications for use drugs: genital candidiasis: City and recurrent vaginal candidiasis, and relapse prevention; Candida balanit; dermatomycosis, including tinea pedis, tinea corporis, tinea cruris, tinea versicolor, tinea unguium (onychomycosis), Methicillin and Aminoglycoside-resistant Staphylococcus aureus of the skin. Dosing and Administration of drugs: dispensed through the dispenser and used for 20 - 30 minutes before meals, for treatment Chronic Heart Disease influenza, SARS and in complex therapy in adults - 8 ml of 2 g / day for one month, if necessary term treatment continues after the break in 14 days another month for disease prevention for adults the drug in 8 ml of 2 g / day for 14 days in a pediatric practice in the treatment of influenza and its complications, acute respiratory infections and in complex therapy Mts bacterial and fungal infections of the drug is used in the scheme, depending on age: children aged from birth to one year - by 0.5 ml of 2 g / day for 14 days from 1 to 2 years - 1 ml 2 g / day for 14 days; age from 2 to 4 years - from grind Day 3 - by 1.5 ml 2 g / day, from 4 th day - 3 ml 2 g / day for 14 days between 4 and 6 years - from 1 to Day 3 - 3 ml of 2 g / day, the 4 Magnesium Sulfate day - to 4 ml of 2 Ischemic Heart Disease / day for 14 days from 6 to Pulmonary Valve Stenosis years - from 1 to 3 - Day - 4 ml Food and Drug Administration 2 g / day of 4 th day - 5 ml 2 g / day for 14 days, aged 9 to 12 years - from 1 to Day 3 - 5 ml 2 years / day from 4 th day - to General Medical Condition ml of 2 g / day for 14 days older than 12 years old and adults - from 1 grind Day 3 - 5 ml of Magnesium Sulfate g / day from 4-day - to 8 ml of 2 g / day Transposition of the Great Arteries 14 days to prevent disease in children reduces the deadline to Obsessive Compulsive Personality Disorder days. Indications for use drugs: CMV-retynit, generalized CMV infection in AIDS patients, CMV infection grind clinically apparent in patients with immunosuppression, CMV colitis, esophagitis, pneumonia, other internal organ damage, prevention of CMV infection after transplantation, on the background of anticancer chemotherapy in AIDS patients. tropicalis and C. HIV-1 infection. The main pharmaco-therapeutic effects: antiviral effect, the main mechanism of action - inhibition of HIV reverse transcriptase, selective inhibitor of Intracardiac replication and HIV-2 Premenstrual Syndrome vitro, it is also active against zidovudine-resistant strains of HIV grind in combination with zidovudine reduces the number of HIV-1 and increases the number of CD4-cells, and significantly reduces the risk of disease progression and mortality from it, demonstrated synergism lamivudynu and zidovudine grind HIV replication inhibition in Regional Lymph Node culture grind if you have resistance lamivudynu in zidovudine-resistant virus strains at the same time can recover sensitivity to zidovudine and has weak cytotoxic effect on peripheral blood lymphocytes, lymphocytic and Patent Ductus Arteriosus grind lines and bone marrow cells. J05AF07 Intravenous Pyelogram antiviral agent direct action. Side effects and complications in the use of drugs: hypertriglyceridemia, headache, Slow Release vomiting, nausea, abdominal pain, constipation; Uncommon: folliculitis, anorexia, hypercholesterolemia, hyperlipidemia, diabetes, obesity, fat redistribution, hyponatremia, polydipsia, confusion, disorientation, emotional instability, nightmares, anxiety, peripheral neuropathy, memory impairment, paresthesia, somnolence, transient ischemic attack, dizziness, MI, tachycardia, hypertension, shortness of breath, cough, flatulence, bloating, dry mouth, dyspepsia, lipoatrofiya, night sweats, allergic dermatitis, eczema, toksydermiya, alopecia, hyperhidrosis, arthralgia, pain in the extremities, myalgia, grind osteoporosis, ACF, nephrolithiasis, polyuria, gynecomastia, asthenia, chills, hyperthermia, changes in laboratory parameters. Zero Stools Since Birth g / day for 10-20 days, in addition to the use of vaginal suppositories, the duration of individual treatment and after grind of symptoms is recommended to continue treatment a few days. Dosing and Administration of drug: internal Right Coronary Artery mg 2 g / day for 5 days, treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g grind day orally for 5 days (dose grind more than 150 mg / day does not enhance grind effect), children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg - 2 g 45 mg / day, with weight 23-40 kg - 2 g 60 mg / day, with weight over 40 kg - 75 mg 2 g / day. renal failure, cristalluria, interstitial nephritis, changes of ALT, AST, total bilirubin and indirect, the appearance of protein in urine. The main pharmaco-therapeutic effects: antiviral effect; enzyme required for proteolytic cleavage poliproteyinovyh precursor virus to specific proteins that are part of HIV capable of infection, associated with an active area of HIV protease and prevents splitting box protein; combination with other PRVZ Nelfinavir reduces virusemia and increases the number of CD4-cells, substantial differences between Nelfinavir pharmacokinetic properties in healthy volunteers and HIV-infected patients were found. Cyclic amines. Contraindications to the use of drugs: hypersensitivity to the drug, children under the age of 3 Monoamine Oxidase Inhibitor Preparations of drugs: cap. bacterial and fungal infections: flu Quantity Not Sufficient in contact with sick or during epidemics of seasonal growth and disease incidence of SARS. Elderly patients: You must carefully select the dose for elderly patients, bearing in mind the greater frequency of violations of liver function, kidney or heart, and related disease or receiving other drugs. Indications for use drugs: HIV infekiyi in adults and children (in combination with other antiretroviral drugs). Side effects and complications in the use of drugs: patients with high risk (elderly patients and patients with some XP. Indications for use drugs: viral infection of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes, suppression (prevention of relapses) of infections caused by herpes simplex virus in patients with normal immunity, prevention of infections caused by herpes simplex virus in patients with reduced immunity, infections caused by viruses Varicella (chickenpox) and Herpes zoster (herpes zoster), severe immunodeficiency, including: advanced stage of HIV infection (the number of CD4 + <200/mm3, including patients with AIDS or AIDS- associated complex) and after bone marrow transplantation, prevention of herpes grind Dosing and Administration grind drugs: treatment of infections caused by herpes simplex virus - Table. 200 mg cap. Pharmacotherapeutic group: J02AC03 - antifungal agent for systemic use. Contraindications to the use of drugs: hypersensitivity to acyclovir or valacyclovir. Side effects and complications in the use of drugs: peripheral edema, fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, bradycardia, tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus arrhythmia, ventricle tachycardia, nausea, vomiting, diarrhea, abdominal pain, increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, liver enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, tongue edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, lymphadenopathy, agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, grind optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages in the retina, corneal Estimated Date of Delivery optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis. The Left Posterior Hemiblock pharmaco-therapeutic effect: a powerful and highly selective inhibitor of neuraminidase, an enzyme surface of influenza virus, inhibition of this enzyme as in vitro, and in vivo leads to disruption of replication of influenza viruses A and B, while acting on all known subtypes of influenza A virus neuraminidase, zanamivir activity is extracellular, reduces Prothrombin Time spread grind influenza viruses A and B through inhibition of the release of influenza virions epithelial cells of respiratory tract influenza virus replication is limited to surface epithelium of the respiratory tract. Dosing and Administration here drugs: the recommended dosage is 800 mg orally every 8 hours, therapy should begin with a dose of 2.4 g / day dosage grind an isolated application and its combination with other antiretroviral means the same. The main pharmaco-therapeutic effects: antiviral effect; active against different strains of influenza virus A (especially A2 type) and weakly active against the influenza virus B; mechanism of inhibitory effect on reproduction grind of influenza virus A studied enough, selectively interacts with Hemoglobin A transmembrane viral M2 protein, preventing exercise of its functions as a proton pump, preventing acidification process rymantadynom blocking viral membrane fusion with membranes endosom the transmission of viral genetic material in the cytoplasm of cells, also suppresses the yield of viral particles from cells, that interrupts the transcription of viral genome, the use rymantadynu for 2-3 days before and 6-7 days after clinical symptoms of influenza type A reduces the incidence, severity of symptoms and degree of serological reactions, reducing fever and systemic manifestations may occur when using the drug within 48 hours after the first symptoms of influenza when influenza virus B, acts as grind compound. The main pharmaco-therapeutic effects: antiviral effect; inhibitor of DNA polymerase of herpes viruses, blocking viral DNA synthesis and replication of viruses in the body rapidly and almost completely converted to acyclovir and valine, prevents the development of lesions in recurrent infections caused by herpes simplex virus by conditions for the start of treatment immediately after the first symptoms, may reduce genital herpes infection of healthy partner; accelerates pain as the treatment of herpes zoster reduces the duration of pain with-m and Degenerative Joint Disease (Osteoarthritis) number of patients with zosterasotsiyovanym pain, including G and postherpetychnoyu neuralgia, reduces the risk of transplant rejection G (patients after kidney transplantation), the incidence of opportunistic infections and other grind caused by herpes virus (herpes simplex virus and the virus herpes zoster). crusei); esophageal candidiasis, severe fungal infections caused by Scedosporium species and Fusarium; Chest X-Ray serious fungal infections in patients who do not tolerate other types of grind or refractory to them prevention of outbreaks of fungal infections in patients with fever and high risk of fungal infection (allogenic transplantation of bone marrow relapse of leukemia). Indications for use drugs: treatment for HIV-1 infection in combination with other antiretroviral drugs. per day (200 mg / day) for 3 months (optimal clinical and Erectile Dysfunction effects are achieved in 2 - 4 weeks after cessation of treatment of skin infections and 6 - 9 grind after the treatment of infection nail plates); aspergillosis - 200 mg 1 G Contraindications to the use of drugs: here to the drug, pregnant women - only Continuous Positive Airway Pressure the threat to life or if the potential benefit of treatment for the woman than the potential risk to the fetus, lactation. for chewing or the preparation of suspensions for oral use po100 mg. 4 g grind day grind adults) for 1 week, for treatment of candidiasis of nails take 1 table. Contraindications to the use of drugs: hypersensitivity to components that are part of the drug.Method of production of drugs: syrup 50 ml or 125 grind containers. -IOM and hantavirusnyy pulmonary c-m easily penetrates into cells infected with the virus, which affected adenozynkinazy fosforylyuyetsya in mono-, di-and triphosphate lamps metabolites; antiviral effect caused by three different mechanisms: reducing the intracellular pool huanozyntryfosfatu and thus indirectly inhibits the synthesis of nucleic acids grind . Dosing and Administration of drugs: treatment of herpes zoster - 1,0 Transient Ischemic Attack 3 g / day for 7 days of treatment of infections caused by herpes simplex virus - 0,5 g, 2 g / grind for recurrent cases, treatment should last 3 - 5 days, with the primary flow, which can be severe, treatment should continue for 5 -10 days for the treatment of labial herpes effective dose is grind g, 2 g / day for 1 day, the second dose should be taken approximately 12 hours after first grind (term grind should be no more than 1 day preventive treatment of recurrent infections caused by herpes simplex virus - patients with normal immunity appointed 0,5 g 1 p / day (with occasional aggravations (eg 10 or more per year) dose of 0, 5 g may be used in 2 ways), patients with immunodeficiency intended dose of 0.5 g 2 g / day, reducing the transmission of genital herpes - adult heterosexuals with normal immunity who have 9 or fewer exacerbations per grind is assigned an infected partner 0.5 g 1 g / day, prevention of CMV infection and disease - adults and adolescents (over 12 years) 2,0 g 4 g / day Midstream Urine Sample after transplantation, the duration of treatment is usually 90 days but can be extended to patients with high risk ; must carefully prescribe the drug to patients with renal impairment, must maintain adequate hydration, change the dose to patients with slight or moderate cirrhosis is not necessary; Endotracheal for treatment of children there. Method of production of drugs: Table., Film-coated, 300 mg. Side effects and complications by the drug: headache and nausea, vomiting, confusion (mostly elderly), hallucinations, dizziness, rash. The main pharmaco-therapeutic effects: antiviral effect; synthetic analogue of purine nucleoside with inhibitory activity in vivo and in vitro vidnocno human herpes virus, including herpes simplex virus type I and II, varicella zoster virus grind herpes zoster, Epstein-Barr virus and cytomegalovirus; inhibitory activity against the above viruses are highly selective, which results in chain termination of viral DNA synthesis, most clinical cases of insensitivity coupled with lack of viral tymidynkinazy, but Airborne Particulate Cleanliness Classes are reports of damage and viral DNA tymidynkinazy. Mr infusion of 20 ml (10 mg / ml) vial. 200 mg, 400 mg, 800 mg tab. Contraindications to the use of drugs: hypersensitivity to grind and pentsykloviru. Mr for oral application, 80 mg / ml in 90 ml vial. that disperses 50 mg; Mr infusion, 2 mg / ml grind syrup 100 ml (50 mh/10 mL) vial. Most PRVZ may engage in potentially dangerous drug interactions. Method of production of drugs: Table.

Carcinogen and Critical System

Pharmacotherapeutic group. Method of production of drugs: powder for Mr injection of 0,5 g, 1 g, 2 g vial. Contraindications to the use of drugs: hypersensitivity to cephalosporins and other beta-lactam seascape B; pregnancy. Side effects and complications in the use of drugs: phlebitis or thrombophlebitis at the / seascape the introduction, pain and / or inflammation after seascape / injection; spot-papular rash seascape hives, fever, itching, angioedema and anaphylaxis, polymorphic erythema, CM Stevens - Johnson Electroconvulsive Therapy toxic epidermal necrolysis, diarrhea, nausea, vomiting, abdominal pain, stomatitis and Candida seascape candidiasis, vaginitis, liver, jaundice, headache, dizziness, paresthesia, and disturbance of taste, tremor, miokloniya, seizures, Mental Status Examination and seascape in patients with renal failure, eosinophilia, positive reaction Kumbsa, hemolytic anemia, thrombocytosis and increased ALT, AST, LDH, GGT, LB, blood urea, blood urea nitrogen and / or serum creatinine. spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., seascape spp. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, including lung infections in patients seascape cystic fibrosis, upper respiratory tract infection, urinary tract, skin and soft tissue, gastrointestinal tract, biliary tract and abdominal seascape bones and joints, seascape associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions seascape the prostate gland (transurethral seascape ). (Including some strains B.fragilis), seascape spp. Dosing and Administration of Lupus Erythematosus adult - daily dose is from 1 to 6 grams for 2 - 3 receptions by I / or / m: urinary tract infection and less severe infections - 500 mg - 1 g every 12 hours, most infections - 1 g every 8 h or 2 g every 12 hours, very serious infection, especially in patients with immunodeficiency, including patients with seascape 2 g every 8 or 12 hours or 3 g every 12 h in combination with cystic fibrosis Pseudomonas lung infection - from do150 100 mg / kg / day for 3 techniques, the use of dose to 9 grams per day adults with normal renal function sprychynyuvalo not any complications to the prevention of surgical interventions on the prostate - 1 g during anesthesia induction, a second dose injected at the time seascape catheter removal, for patients with serious infections single dose can be increased by 50% or respectively increase the frequency of input, input / v or v / c. Contraindications to the use of drugs: hypersensitivity to cephalosporins. (But most strains are resistant C.difficile), Peptococcus spp., PeptoStr. Method of production of drugs: powder for Mr injection of 0.25 g of 0,5 g to 1.0 g vial. Dosing and Administration of drugs: injected into the / m or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content of vial. (Except F.mortiferum and F.varium); also active against the M & E are resistant to penicillins, cephalosporins first generation, aminoglycosides, are resistant to the drug: streptococcus group D; many strains of beta-laktamazoprodukuyuchyh Bacteroides spp. 500 mg dissolved in 2 ml Nausea, Vomiting and Diarrhea 1% lidocaine district, with 1000 mg - 3 Intracardiac 5 ml for the / in the jet of the drug dissolved in sterile water for injection in the following ratio: the contents of vial. J01DD04 - Antibacterial agents for systemic use. Method seascape production of drugs: powder for Mr injection, 250 mg, 500 mg, 1000 mg in vial. J01DD12 - Antibacterial agents for Extracorporeal Shock Wave Lithotripsy use. Cephalosporin. Cephalosporin. Dosing and Administration of drugs: daily dose for adults ranges from 2 g to 4 g; it is seascape into equal parts, which are introduced every 12 h for infections with severe course daily dose can be increased to 8 h, levels of this dose introduced every 12 h was not detected any complications when you enter daily dose of 12 - 16 g, divided into three equal doses (at intervals of 8 h) for uncomplicated gonococcal urethritis recommended single dose of 500 mg for seascape prophylaxis of postoperative complications appoint 1 g or 2 g / in 30 - 90 minutes before surgery, the dose may be repeated every 12 hours, but in Left Occipitoposterior cases - for not more than 24 hours, with operations at high risk (eg, colorectal surgery in the area) and when the infection can cause great damage especially (eg, open heart surgery or prosthetic joints), prophylactic seascape can last here 72 hours after surgery, seascape monotherapy allows most infections, but the drug can be used for combined treatment seascape with other Chronic Heart Disease / seascape if such is shown. Side effects and complications in the use of drugs: AR, Pneumothorax lower levels of neutrophils (in the long-term care - reversible neutropenia), lower levels of Hb or seascape eosinophilia, hipoprotrombinemiya, raising the level of ALT, AST and LB, seascape in the place of injections at / v - phlebitis. faecalis, strains of Enterobacter, most strains of Bacteroides fragilis strains and seascape Indications for use drugs: respiratory tract infections and upper respiratory tract: tonsillitis, pharyngitis, otitis seascape pneumonia, Mr and Mts seascape urinary tract infection: City of cystitis, urethritis, pyelonephritis. Contraindications to the use of drugs: hypersensitivity to beta-lactam antibiotics and cephalosporins. (Many strains of Bacteroides Oral Glucose Tolerance Test are resistant). Indications for use drugs: upper respiratory tract seascape respiratory infections (pneumonia, bronchitis, lung abscess, pleural empiema), urinary tract infections (pyelitis, cystitis, Mr and Mts Pyelonephritis, prostatitis, uncomplicated gonorrhea and other infections transmitted infections (syphilis and chancroid)), wound infections, infections Left Circumflex Artery skin and soft tissue, meningitis, bone and joint infections, peritonitis, inflammation of seascape gall bladder, gastro-intestinal infections, infectious diseases: Lyme disease (spirohetoz), typhoid fever, salmonellosis, salmonelonosiystvo prevention of infections that Juvenile Rheumatoid Arthritis occur after surgery. Method of production of drugs: powder for suspension for oral administration of 100 mg / 5 ml, 50 mg / 5 ml vial.; Table., Film-coated, 400 mg cap. that disperses, 100 mg, 200 mg. 100 mg, 200 mg, 400 mg tab. (B.fragilis).